Secretion both DNA and proteins. It was discovered in "Agrobacterium tumefaciens", which uses this system to introduce the T-DNA portion of the Ti plasmid into the plant host, which in turn causes the affected area to develop into a crown gall (tumor). "Helicobacter pylori" uses a type IV secretion system to deliver CagA into gastric epithelial cells, which is associated with gastric carcinogenesis. "Bordetella pertussis", the causative agent of whooping cough, secretes the pertussis toxin partly through the type IV system. "Legionella pneumophila", the causing agent of legionellosis (Legionnaires' disease) utilizes a type IVB secretion system, known as the icm/dot (intracellular
Schindler disease of the disease is mostly palliative. However, Type II Schindler disease, with its late onset of symptoms, is not characterized by neurological degeneration. There is no known cure for Schindler disease, but bone marrow transplants have been trialed, as they have been successful in curing other glycoprotein disorders. Schindler disease was named after Detlev Schindler (1946- ) M.D., the first author of a 1988 paper detailing the disease. It also named after the Japanese Biochemist and Physician, Hiro Kanzaki (1949- ), who further studied it and released papers detailing the disease in 2006. Schindler disease Schindler disease, also known as